You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Indirect Detection of Radiological and Nuclear Threats by Secondary Effects in Electromagnetic Materials
SBC: PNTS INCORPORATED Topic: DTRA133002ABSTRACT: The PNTS team has team has defined a schema using an active metamaterial exhibiting an externally driven electromagnetic response driven by the sensing of external radiation effects. The novel, groundbreaking concept, employs a semiconductor slab hosting BENEFITS: The team feels that its novel capabilities, with the potential for low cost for manufacturing and implementation, in the mos ...
SBIR Phase I 2014 Department of DefenseDefense Threat Reduction Agency -
Enhancing Augmentative and Alternative Communication Rates in pre-K Through 6
SBC: Speak Agent, Inc. Topic: N/AThe project team is developing a prototype of a tool for touch-screen mobile devices to support students in pre-kindergarten to grade 6 who have special communication needs. The product will include artificial intelligence software that will adapt the prompts and cues to the needs of individual students. In the Phase I pilot research, the team will examine whether the prototype functions as planne ...
SBIR Phase I 2014 Department of Education -
Low-power, Small Form-factor Benzene Sensor for Mobile Devices-based Exposure Monitoring
SBC: N5 SENSORS INC Topic: DMeasuring individual exposure in real-time can revolutionize air quality monitoring in communities everywhere. Such information would allow citizens to take preventive measures to reduce their exposures to air toxics, which would impact their health and quality of life tremendously. Mobile devices such as smart-phones and tablets represent a powerful infrastructure that could be leveraged to devel ...
SBIR Phase I 2014 Environmental Protection Agency -
Innate Defense Regulator Peptide as a Therapeutic for Acute Pneumonic Melioidosis
SBC: Soligenix, Inc Topic: NIAIDDESCRIPTION (provided by applicant): This proposal describes development of an immunomodulatory peptide that targets the host defense system for treatment of acute pneumonic melioidosis. The disease is caused by Burkholderia pseudomallei (Bps), a non-spore-forming motile saprophytic bacterium that can be transmitted from the soil to humans by inhalation, through cuts in the skin and by ingestion. ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Increasing viability of lung organs for transplantation
SBC: TRIM-EDICINE INC Topic: NIAIDDESCRIPTION (provided by applicant): While organ transplantation is a vital last resort therapy to treat patients with end-organ failure of the lung there is a growing waiting list of patients who are eligible for transplants as the number of suitable donor organs fall far short of the demand for these lifesaving procedures. Improving the preservation of donated organs so that a greater percentage ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine
SBC: PROFECTUS BIOSCIENCES, INC. Topic: NIAIDDESCRIPTION: There is a growing consensus that protection against HIV infection will require BOTH antiviral antibody responses as well as polyfunctional CD4+ and CD8+ T cells with potent lytic activity. To stimulate the breadth, potency, and rate of response required, Profectus Biosciences intends to utilize its platform technologies based on electroporation of DNA vaccines combined with genetic a ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Spiral Countercurrent Chromatography for High-throughput Natural Product Purifica
SBC: CC BIOTECH LLC Topic: NCCIHDESCRIPTION (provided by applicant): Recent advances in countercurrent chromatography (CCC) have created novel spiral-design separation columns that hold a very high stationary phase of all the solvent systems, such that now all molecules of any size and water solubility can be successfully separated in high-speed countercurrent chromatography. With spiral CCC there is inherent versatility, more t ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Real-time qPCR assay for detection of ALT associated telomeric C-circle DNA in bl
SBC: Capital Biosciences, Inc. Topic: NCIDESCRIPTION (provided by applicant): The overall goal of the proposed project is to investigate the feasibility of employing real-time qPCR method for detection of telomeric C-circle DNA in peripheral blood of patients with cancers that utilize Alternative Lengthening of Telomeres (ALT) as their Telomere length Maintenance Mechanism (TMM). Telomeric C-Circle DNA has been demonstrated to be specif ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Biomarker Breast Pap Test
SBC: SILBIOTECH, INC. Topic: NCIDESCRIPTION (provided by applicant): This Phase I research proposal is to investigate the feasibility of developing a novel Biomarker Breast PapTest for screening Nipple Aspirate Fluid (NAF) and detecting breast cancers at the tumor-in-formation stage before mammographically detectable tumors are developed. Although there is a slight decline in deaths from breast cancer in recent years, it conti ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
TRAIL Upregulation by TIC10 Analogs
SBC: PROVID PHARMACEUTICALS INC. Topic: NCIProject Summary/Abstract TIC10 (ONC201) is a first-in-class antitumor agent and small molecule inducer of the TRAIL gene which was identified in a high-throughput small molecule library screen in the lab of our collaborator, Dr. Wafik El-Deiry at Penn State University and has been shown to have preclinical efficacy in several difficult-to-treat disease settings that include unmet clinical needs su ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health